scorecardresearch
Sunday, November 3, 2024
TopicOxford vaccine

Topic: Oxford vaccine

Delaying 2nd AstraZeneca vaccine shot by upto 45 weeks improves immune response: Oxford study

A preprint of the study by researchers of Oxford University noted that a third dose of the AstraZeneca vaccine will also lead to a substantial increase in immune response.

Covid-19 pandemic: Brussels seeks EU unity over AstraZeneca, push for J&J vaccine in Hong Kong

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Study of Oxford-AstraZeneca vaccinations in children paused after blood clots emerge in adults

UK’s drug regulator is investigating rare cases of blood clots in adults who were given Oxford-AstraZeneca shot. No safety issues have arisen in children’s trial, Oxford says.

Drug regulator DCGI extends shelf life of Covishield vaccine from 6 to 9 months

In a letter to the Serum Institute, Drugs Controller General of India Somani said the institute is permitted to apply the shelf life of 9 months to unlabeled vials available on hand.

Govt tracking AstraZeneca vaccine ‘blood clot’ issue, but no ‘signal of concern’ yet

NITI Aayog’s Member (Health) Dr V.K. Paul says vaccinations with the Serum Institute of India-made Covishield will continue ‘with full vigour’.

Oxford-AstraZeneca vaccine safe and works extremely well, says UK PM Boris Johnson

Amid reports that doses were causing blood clot-related complications, Johnson said that six months since its discovery, multiple countries like India are producing the vaccine.

3-month gap between doses of Oxford vaccine more effective against Covid, Lancet study finds

According to Oxford University researchers, the first dose of the vaccine offers 76% protection, making it safe for the interval between doses to be extended to 3 months.

Serum Institute, UNICEF sign pact for supply of 1.1 billion doses of AstraZeneca, Novavax

UNICEF will have access to these vaccines for around 100 countries, for approximately USD 3 a dose for the low- and lower middle-income countries.

Covaxin a ‘buffet’ vaccine that can deal with mutations, others ‘a la carte’ — top virologist

India’s vaccination strategy is smartly-designed and will strengthen healthcare workers to handle a second wave, says Dr V. Ravi, former basic sciences dean at NIMHANS.

Malaysia healthcare at ‘breaking point’, UK pharmacies set to offer vaccine & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe. 

On Camera

As a Hindu Canadian, I am deeply hurt by cancellation of Diwali. My community is now sidelined

Canada faces serious foreign interference issues, but these challenges must not be weaponized to unfairly target friendly and important allies like India.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Indian firms sanctioned by US didn’t violate laws, says MEA. Hyderabad firm that supplied to Army on list

Among 19 Indian firms sanctioned by US Treasury Dept was Lokesh Machines Ltd accused of coordinating with 'Russian defence procurement agent to import Italy-origin CNC machines'.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.